{"id":"gelatin","rwe":[{"pmid":"41906015","year":"2026","title":"Development and Pre-clinical Feasibility of a Catheter-Based Platform for Interventional Phase-0 Drug Response Measurements.","finding":"","journal":"Annals of biomedical engineering","studyType":"Clinical Study"},{"pmid":"41904264","year":"2026","title":"Multimodal intra-subject characterization of abdominal aortic aneurysm pathophysiology: a case study.","finding":"","journal":"Biomechanics and modeling in mechanobiology","studyType":"Clinical Study"},{"pmid":"41903972","year":"2026","title":"Novel microfluidic gelatin-paper-based chip for sensitive colorimetric detection of urine albumin.","finding":"","journal":"Analytica chimica acta","studyType":"Clinical Study"},{"pmid":"41903697","year":"2026","title":"Valorization of dragon fruit peel into advanced functional carbon quantum dot/betalain composite films for smart and active beef packaging.","finding":"","journal":"Bioresource technology","studyType":"Clinical Study"},{"pmid":"41903101","year":"2026","title":"Treatment of myocardial infarction via implantation of electroactive alginate/gelatin cardiac patch seeded with mesenchymal stem cells in a rat model.","finding":"","journal":"Drug delivery and translational research","studyType":"Clinical Study"}],"_fda":{"id":"2b082a35-29b6-345e-e063-6394a90a6246","set_id":"24ceba32-eb30-902f-e063-6394a90a9fd5","openfda":{"nui":["N0000010282"],"unii":["92RU3N3Y1O"],"route":["ORAL"],"rxcui":["252294"],"spl_id":["2b082a35-29b6-345e-e063-6394a90a6246"],"brand_name":["Ultrastrength Gas Relief"],"spl_set_id":["24ceba32-eb30-902f-e063-6394a90a9fd5"],"package_ndc":["51316-621-76"],"product_ndc":["51316-621"],"generic_name":["SIMETHICONE SOFT GELATIN CAPSULES"],"product_type":["HUMAN OTC DRUG"],"pharm_class_pe":["Skin Barrier Activity [PE]"],"substance_name":["DIMETHICONE"],"manufacturer_name":["CVS PHARMACY, INC"],"application_number":["M002"],"is_original_packager":[true]},"purpose":["Purpose Anti-gas"],"version":"2","warnings":["​Warning Keep out of reach of children."],"questions":["Questions or comments? Call 1-877-290-4008"],"effective_time":"20250129","active_ingredient":["Active ingredient (in each softgel) Simethicone 180 mg"],"inactive_ingredient":["Inactive ingredients FD&C yellow no. 6, gelatin, glycerol, medium chain triglyceride, peppermint oil, propylene glycol, purified water, shellac, sorbitol sorbitan solution, titanium dioxide"],"indications_and_usage":["Use for the relief of pressure and bloating commonly referred to as gas."],"other_safety_information":["Other information store at room temperature protect from light, heat and moisture"],"spl_unclassified_section":["Drug Facts"],"dosage_and_administration":["Directions adults: swallow with water 1 or 2 softgels as needed after meals and at bedtime do not exceed 2 softgels in 24 hours except under the advice and supervision of a physician"],"spl_product_data_elements":["Ultrastrength Gas Relief Simethicone Soft Gelatin Capsules SHELLAC DIMETHICONE DIMETHICONE GLYCERIN PEPPERMINT OIL SORBITAN FD&C YELLOW NO. 6 MEDIUM-CHAIN TRIGLYCERIDES SORBITOL WATER PROPYLENE GLYCOL TITANIUM DIOXIDE GELATIN 107 Orange opaque"],"keep_out_of_reach_of_children":["Keep out of reach of children."],"package_label_principal_display_panel":["CVS_721T_50ct"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"llr":99.278,"date":"","count":12,"signal":"Hepatic artery stenosis","source":"DrugCentral FAERS","actionTaken":"Reported 12 times (LLR=99)"},{"llr":53.327,"date":"","count":21,"signal":"Aspartate aminotransferase increased","source":"DrugCentral FAERS","actionTaken":"Reported 21 times (LLR=53)"},{"llr":40.11,"date":"","count":18,"signal":"Alanine aminotransferase increased","source":"DrugCentral FAERS","actionTaken":"Reported 18 times (LLR=40)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=GELATIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:22:21.963404+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:22:27.546853+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GELATIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:22:27.964244+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:22:20.689938+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:22:20.689965+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108518/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:22:28.665347+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M002","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:22:20.689969+00:00"}},"allNames":["gelatin"],"offLabel":[],"synonyms":["gelatin"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"GELATIN's mechanism of action is likely to involve binding to a specific molecular target, such as a protein or receptor, to produce a conformational change that alters its activity. This can result in changes to downstream signaling pathways, leading to changes in cellular behavior and potentially therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5549","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=GELATIN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GELATIN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T13:47:03.454268","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:22:30.697651+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"genericName":"gelatin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07450833","phase":"PHASE1","title":"Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers","status":"COMPLETED","sponsor":"Benfovir AG","startDate":"2022-03-01","conditions":["Healthy Volunteers"],"enrollment":48,"completionDate":"2022-11-21"},{"nctId":"NCT07495176","phase":"NA","title":"USC-Exos in Corpus Spongiosum Reconstruction for Hypospadias","status":"COMPLETED","sponsor":"Shanghai Children's Hospital","startDate":"2021-02-01","conditions":["Hypospadias"],"enrollment":82,"completionDate":"2025-12-31"},{"nctId":"NCT03574909","phase":"PHASE3","title":"IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes","status":"COMPLETED","sponsor":"Royal College of Surgeons, Ireland","startDate":"2018-09-01","conditions":["Pre-Gestational Diabetes"],"enrollment":137,"completionDate":"2023-08-25"},{"nctId":"NCT07498218","phase":"PHASE1","title":"Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue","status":"NOT_YET_RECRUITING","sponsor":"Ayu, Inc.","startDate":"2026-03-02","conditions":["Diabetic Foot Ulcer (DFU)","Granulation of Chronic Diabetic Wounds"],"enrollment":24,"completionDate":"2026-10-13"},{"nctId":"NCT07027826","phase":"NA","title":"The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":["Dysphagia","Eosinophilic Esophagitis"],"enrollment":70,"completionDate":"2027-08-31"},{"nctId":"NCT06567548","phase":"NA","title":"Clinical Comparison of Alb-PRF vs PRF on Postoperative Morbidity Following FGG Harvesting","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-11-27","conditions":["Palate; Wound"],"enrollment":39,"completionDate":"2027-01-30"},{"nctId":"NCT07111065","phase":"PHASE2","title":"FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Environmental Health Sciences (NIEHS)","startDate":"2026-04-01","conditions":["Dermatomyositis (DM)","Juvenile Dermatomyositis (JDM)"],"enrollment":300,"completionDate":"2031-11-03"},{"nctId":"NCT07284316","phase":"PHASE2,PHASE3","title":"Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-02-20","conditions":["Cognitive Decline","Subjective Cognitive Impairment","Insulin Resistance"],"enrollment":100,"completionDate":"2027-02-15"},{"nctId":"NCT07172451","phase":"PHASE4","title":"Gelaspan vs Crystalloid Therapy in Sepsis","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-02-13","conditions":["Sepsis","Intra-Abdominal Infections"],"enrollment":318,"completionDate":"2028-12-30"},{"nctId":"NCT06517758","phase":"PHASE3","title":"A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-07-31","conditions":["Generalized Myasthenia Gravis"],"enrollment":146,"completionDate":"2032-05-27"},{"nctId":"NCT05430152","phase":"PHASE2","title":"Low-dose Naltrexone for Post-COVID Fatigue Syndrome","status":"COMPLETED","sponsor":"Luis Nacul","startDate":"2024-01-15","conditions":["Post-Viral Fatigue Syndrome"],"enrollment":160,"completionDate":"2026-02-28"},{"nctId":"NCT06676371","phase":"NA","title":"Total Arch Replacement With Frozen Elephant Trunk Versus Hemiarch Replacement in the Management of Acute Type A Aortic Dissection","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2026-10","conditions":["Aortic Dissection Type A"],"enrollment":150,"completionDate":"2029-10"},{"nctId":"NCT07241585","phase":"NA","title":"Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)","status":"NOT_YET_RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2026-05-01","conditions":["Nonmelanoma Skin Cancer","Basal Cell Carcinoma","Squamous Cell Carcinoma"],"enrollment":54,"completionDate":"2027-08"},{"nctId":"NCT07477223","phase":"NA","title":"Beef Versus Whey Protein: The Gut Showdown Self-Experiment","status":"RECRUITING","sponsor":"Efforia, Inc","startDate":"2026-02-06","conditions":["Digestion"],"enrollment":100,"completionDate":"2027-02-06"},{"nctId":"NCT05406362","phase":"PHASE1,PHASE2","title":"Assess Safety and Efficacy of VAD044 in HHT Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vaderis Therapeutics AG","startDate":"2022-07-18","conditions":["Hereditary Hemorrhagic Telangiectasia (HHT)"],"enrollment":75,"completionDate":"2027-01"},{"nctId":"NCT06404203","phase":"NA","title":"The Effect of Oral Use of Lyophilised Royal Jelly on Cognitive Functions and Immune System in Elderly Individuals","status":"COMPLETED","sponsor":"Medipol University","startDate":"2024-07-01","conditions":["Cognitive Change","Cytokine Levels","Neuroinflammation"],"enrollment":120,"completionDate":"2026-01-15"},{"nctId":"NCT07110532","phase":"PHASE1","title":"pH1N1 Blinded Challenge Study","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-09-10","conditions":["Influenza"],"enrollment":180,"completionDate":"2026-08-18"},{"nctId":"NCT04620759","phase":"PHASE2","title":"Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2021-04-14","conditions":["Major Depressive Disorder","Alcohol Use Disorder"],"enrollment":90,"completionDate":"2027-03-30"},{"nctId":"NCT07466485","phase":"PHASE2","title":"The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD)","status":"RECRUITING","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2026-03-02","conditions":["Alcoholic Fatty Liver Disease"],"enrollment":26,"completionDate":"2026-12-15"},{"nctId":"NCT04417621","phase":"PHASE2","title":"Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2020-10-30","conditions":["Melanoma"],"enrollment":134,"completionDate":"2027-02-02"},{"nctId":"NCT06442423","phase":"PHASE1","title":"Open-Label Psilocybin Study in Transdiagnostic Population","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-10-17","conditions":["Transdiagnostic","Depression - Major Depressive Disorder","Anxiety","PTSD Symptoms","PTSD","Substance Use","Substance Use Disorder (SUD)","OCD"],"enrollment":50,"completionDate":"2027-12"},{"nctId":"NCT07459829","phase":"PHASE2","title":"Study of CU06-1004 in Patients With Daibetic Macular Edema","status":"NOT_YET_RECRUITING","sponsor":"Curacle Co., Ltd.","startDate":"2026-12-01","conditions":["DME","Diabetic Macular Edema","Diabetic Macular Edema (DME)"],"enrollment":156,"completionDate":"2028-01-30"},{"nctId":"NCT07304843","phase":"PHASE1,PHASE2","title":"A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction","status":"RECRUITING","sponsor":"Umecrine Cognition AB","startDate":"2023-04-14","conditions":["Primary Biliary Cholangitis (PBC)"],"enrollment":84,"completionDate":"2026-06-30"},{"nctId":"NCT05672108","phase":"PHASE2","title":"Phase II Trial of Lung Chemoemobolization","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2023-05-12","conditions":["Lung Non-Small Cell Carcinoma","Mediastinal Neoplasm","Pleural Neoplasm","Lung Metastases From Any Primary","Endobronchial Metastases","Colon Cancer","Sarcoma"],"enrollment":30,"completionDate":"2027-10-28"},{"nctId":"NCT05385952","phase":"NA","title":"GATT-Patch Versus TachoSil in Liver Surgery","status":"COMPLETED","sponsor":"GATT Technologies BV","startDate":"2022-08-04","conditions":["Intraoperative Bleeding","Hemorrhage, Surgical","Liver Diseases"],"enrollment":132,"completionDate":"2024-05-10"},{"nctId":"NCT05285982","phase":"PHASE3","title":"A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2022-04-06","conditions":["Lung Diseases, Interstitial"],"enrollment":54,"completionDate":"2025-08-13"},{"nctId":"NCT06867055","phase":"NA","title":"Evaluation of the Effectiveness of Different Procedures on Palatinal Wound Healing After Free Gingival Graft Surgery.","status":"COMPLETED","sponsor":"SEVAL CEYLAN ŞEN","startDate":"2023-05-15","conditions":["Insufficient Keratinized Gingiva"],"enrollment":67,"completionDate":"2025-09-15"},{"nctId":"NCT07449065","phase":"","title":"CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCC","status":"COMPLETED","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2018-06-01","conditions":["Hepatocellular Carcinoma (HCC)","Transarterial Chemoembolization","Microvascular Invasion (MVI)","Tyrosine Kinase Inhibitors"],"enrollment":324,"completionDate":"2025-10-31"},{"nctId":"NCT05301608","phase":"PHASE1,PHASE2","title":"Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-03-03","conditions":["Healthy"],"enrollment":30,"completionDate":"2026-11-01"},{"nctId":"NCT07439601","phase":"NA","title":"Long-Term Omega-3 and Omega-3 Index >8%: Effects on Physiological Recovery","status":"NOT_YET_RECRUITING","sponsor":"St. Mary's University, Twickenham","startDate":"2026-02-28","conditions":["Focus on Omega 3 Index on Recovery"],"enrollment":46,"completionDate":"2028-12-30"},{"nctId":"NCT07439068","phase":"PHASE2","title":"A-PRF and CGF in Palatal Donor Site Healing","status":"COMPLETED","sponsor":"Ordu University","startDate":"2020-11-01","conditions":["Free Gingival Graft"],"enrollment":45,"completionDate":"2022-05-31"},{"nctId":"NCT07440394","phase":"NA","title":"Evaluation of Pine Bark Extract for Anti-fatigue Ergogenic Properties","status":"COMPLETED","sponsor":"China Medical University Hospital","startDate":"2023-04-21","conditions":["Healthy"],"enrollment":14,"completionDate":"2023-12-31"},{"nctId":"NCT07322003","phase":"PHASE3","title":"Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS","status":"RECRUITING","sponsor":"Prilenia","startDate":"2026-02-01","conditions":["Amyotrophic Lateral Sclerosis"],"enrollment":500,"completionDate":"2029-03"},{"nctId":"NCT06315010","phase":"PHASE2","title":"REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis","status":"RECRUITING","sponsor":"MedSIR","startDate":"2025-06-27","conditions":["NSCLC","Brain Metastases","ROS1 Gene Rearrangement"],"enrollment":20,"completionDate":"2028-04"},{"nctId":"NCT03165734","phase":"PHASE3","title":"A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis","status":"RECRUITING","sponsor":"Swedish Orphan Biovitrum","startDate":"2017-06-26","conditions":["Primary Myelofibrosis","Post-polycythemia Vera Myelofibrosis","Post-essential Thrombocythemia Myelofibrosis"],"enrollment":399,"completionDate":"2027-07-30"},{"nctId":"NCT06871579","phase":"NA","title":"Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-06-11","conditions":["Helicobacter Pylori"],"enrollment":25,"completionDate":"2027-01-30"},{"nctId":"NCT07371169","phase":"NA","title":"Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance","status":"COMPLETED","sponsor":"Uruk University","startDate":"2025-01-01","conditions":["Insulin Resistance","Acanthosis Nigricans"],"enrollment":90,"completionDate":"2026-01-01"},{"nctId":"NCT05807139","phase":"PHASE1","title":"Spironolactone in Alcohol Use Disorder (SAUD)","status":"RECRUITING","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2023-07-13","conditions":["Alcohol Use Disorder"],"enrollment":20,"completionDate":"2027-04-30"},{"nctId":"NCT07394933","phase":"NA","title":"Guided Bone Regeneration Using Ti-Reinforced PTFE Membrane Vs. Khoury's Technique in Augmentation of Posterior Mandibular Defects","status":"ACTIVE_NOT_RECRUITING","sponsor":"British University In Egypt","startDate":"2025-06-15","conditions":["Atrophic Ridge"],"enrollment":16,"completionDate":"2026-04"},{"nctId":"NCT07279558","phase":"PHASE2","title":"Cannabidiol and Alcohol Use Disorder Phenotypes","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-02-01","conditions":["Alcohol Use Disorder"],"enrollment":180,"completionDate":"2029-08-31"},{"nctId":"NCT06229080","phase":"NA","title":"Short-term Embolization Using Gelatin Particles for FloW ModulAtion During Y90 Radioembolization","status":"COMPLETED","sponsor":"Next Biomedical Co., Ltd.","startDate":"2023-03-15","conditions":["Liver Cancer (Primary and Metastatic)"],"enrollment":20,"completionDate":"2025-07-30"},{"nctId":"NCT05900037","phase":"NA","title":"GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery","status":"COMPLETED","sponsor":"GATT Technologies BV","startDate":"2023-10-02","conditions":["Intraoperative Bleeding","Liver Diseases","Gallbladder Diseases","Hemorrhage, Surgical"],"enrollment":53,"completionDate":"2025-08-05"},{"nctId":"NCT07078383","phase":"NA","title":"A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta","status":"RECRUITING","sponsor":"Vascutek Ltd.","startDate":"2025-12-19","conditions":["Aortic Aneurysm","Aortic Aneurysm and Dissection","Aortic Diseases","Aneurysm of Aorta, Thoracic","Aneurysmal Disease","Aorta, Thoracic Pathologies"],"enrollment":150,"completionDate":"2028-11"},{"nctId":"NCT02584933","phase":"PHASE4","title":"Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2015-12-11","conditions":["ALK Positive Malignancies"],"enrollment":233,"completionDate":"2027-06-09"},{"nctId":"NCT07087691","phase":"NA","title":"Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2025-12-22","conditions":["Breast Cancer"],"enrollment":60,"completionDate":"2028-09"},{"nctId":"NCT07381881","phase":"NA","title":"GEL-AID: Safe and Effective Hydration for Institutionalized Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Universitat de Lleida","startDate":"2026-02-23","conditions":["Dehydration","Urinary Infections","Respiratory Infections","Daily Fluid Intake","Mortality"],"enrollment":156,"completionDate":"2027-12-31"},{"nctId":"NCT07072546","phase":"NA","title":"Chitosan and i-PRF in Palatal Wound Healing","status":"COMPLETED","sponsor":"Biruni University","startDate":"2025-07-12","conditions":["Free Gingival Graft","Wound Healing","i-PRF","Chitosan"],"enrollment":68,"completionDate":"2025-12-10"},{"nctId":"NCT07339956","phase":"EARLY_PHASE1","title":"Yiwei Jiaohuang Ointment for Gastrointestinal Bleeding Associated With Oral Antithrombotic Agents","status":"NOT_YET_RECRUITING","sponsor":"China-Japan Friendship Hospital","startDate":"2026-01-10","conditions":["Gastrointestinal Bleeding"],"enrollment":60,"completionDate":"2026-08-30"},{"nctId":"NCT07366320","phase":"NA","title":"Effects of Four-Week Rhodiola Rosea Supplementation on Physical Fitness, Neuromuscular Performance, and Decision-Making in Competitive Football Players","status":"COMPLETED","sponsor":"Beijing Sport University","startDate":"2025-08-30","conditions":["Physical Performance and Fatigue in Competitive Football Players"],"enrollment":24,"completionDate":"2025-10-04"},{"nctId":"NCT07359547","phase":"NA","title":"Comparing XEN®-63 Gel Stent and PRESERFLO® MicroShunt","status":"RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2026-01","conditions":["GLAUCOMA 1, OPEN ANGLE, D (Disorder)"],"enrollment":166,"completionDate":"2028-01"},{"nctId":"NCT07356531","phase":"NA","title":"Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer","status":"RECRUITING","sponsor":"JIANGSU SHENMING Medical Technology CO., Ltd","startDate":"2024-07-29","conditions":["Liver Cancer"],"enrollment":216,"completionDate":"2026-05-31"},{"nctId":"NCT01988883","phase":"EARLY_PHASE1","title":"Modafinil and Cognitive Function in POTS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2014-10","conditions":["Postural Tachycardia Syndrome"],"enrollment":20,"completionDate":"2026-12"},{"nctId":"NCT07336849","phase":"NA","title":"Transcatheter Arterial Embolization Using Nexsphere-F for Chronic Shoulder Pain Refractory to Conservative Treatment","status":"RECRUITING","sponsor":"Chung-Ang University Hosptial, Chung-Ang University College of Medicine","startDate":"2025-09-18","conditions":["Adhesive Capsulitis of the Shoulder","Frozen Shoulder","Shoulder Adhesive Capsulitis"],"enrollment":44,"completionDate":"2027-08-31"},{"nctId":"NCT06027554","phase":"PHASE2","title":"The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults","status":"RECRUITING","sponsor":"UConn Health","startDate":"2024-10-07","conditions":["Frailty","Mild Cognitive Impairment","Aging"],"enrollment":60,"completionDate":"2028-02-01"},{"nctId":"NCT04221503","phase":"PHASE2","title":"Niraparib/TTFields in GBM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2019-12-30","conditions":["Glioblastoma","Recurrent Glioblastoma","GBM"],"enrollment":30,"completionDate":"2026-01"},{"nctId":"NCT07322848","phase":"PHASE3","title":"DEB-TACE vs cTACE in HCC After TIPS","status":"RECRUITING","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2025-12-01","conditions":["Hepatocellular Carcinoma (HCC)","TACE","TIPS","DEB-TACE","cTACE"],"enrollment":206,"completionDate":"2029-12-31"},{"nctId":"NCT07320391","phase":"NA","title":"Ozonated Gel and Titanium Platelet-rich Fibrin (on Palatal Wound Healing","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-05-01","conditions":["Palatal Lesion"],"enrollment":39,"completionDate":"2025-05-30"},{"nctId":"NCT07306403","phase":"NA","title":"THE COMPARISON OF GELATIN SPONGE TO SUTURE ALONE ON POST OPERATIVE SWELLING AFTER EXTRACTION OF IMPACTED MANDIBULAR THIRD MOLAR.","status":"COMPLETED","sponsor":"Watim Medical & Dental College","startDate":"2024-08-30","conditions":["Post Operative Swelling","Impacted Mandibular Third Molar Extraction"],"enrollment":60,"completionDate":"2025-03-30"},{"nctId":"NCT02435953","phase":"PHASE3","title":"TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma","status":"COMPLETED","sponsor":"Ming Zhao","startDate":"2015-02","conditions":["Hepatocellular Carcinoma","Chemoembolization, Therapeutic","Ablation Techniques, RFA"],"enrollment":242,"completionDate":"2025-10"},{"nctId":"NCT03895567","phase":"PHASE1","title":"Study to Compare Blood Levels of Ceftriaxone Given by Suppository or Injection.","status":"SUSPENDED","sponsor":"University of Oxford","startDate":"2026-12","conditions":["Healthy"],"enrollment":37,"completionDate":"2026-12"},{"nctId":"NCT07263139","phase":"PHASE2","title":"Safety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)","status":"RECRUITING","sponsor":"Agiana Pharmaceuticals","startDate":"2026-01-02","conditions":["Catecholaminergic Polymorphic Ventricular Tachycardia"],"enrollment":10,"completionDate":"2027-06-30"},{"nctId":"NCT04783233","phase":"","title":"Chitogel CSK-4 Gel as Packing in Tympanoplasty Surgery","status":"WITHDRAWN","sponsor":"Henry Ford Health System","startDate":"2021-01-14","conditions":["Tympanoplasty Surgery"],"enrollment":0,"completionDate":"2021-11-03"},{"nctId":"NCT06797817","phase":"PHASE3","title":"Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain","status":"NOT_YET_RECRUITING","sponsor":"Universidad de Almeria","startDate":"2026-06-01","conditions":["Alzheimer Disease (AD)"],"enrollment":156,"completionDate":"2029-09-02"},{"nctId":"NCT07281664","phase":"NA","title":"Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2026-01-01","conditions":["Hepatocellular Carcinoma","Transarterial Chemoembolization"],"enrollment":30,"completionDate":"2029-12-31"},{"nctId":"NCT07279909","phase":"PHASE3","title":"Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hamdard University","startDate":"2024-03-09","conditions":["Diabetes Type 2","Diabetes Mellitus, Experimental","HbA1c","Urinary Glucose","Ability of Experimental Drug to Lower HbA1c Compare to Metformin"],"enrollment":500,"completionDate":"2026-05-20"},{"nctId":"NCT07268573","phase":"NA","title":"Effects of Caffeine and L-Theanine on Physical and Cognitive Performance in Trained Athletes","status":"COMPLETED","sponsor":"Ulaş Can YILDIRIM","startDate":"2025-08-01","conditions":["Cognitive Performance","Physical Performance Enhancement","Caffeine and L-theanine Interaction"],"enrollment":20,"completionDate":"2025-08-14"},{"nctId":"NCT02307916","phase":"PHASE2","title":"Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations","status":"COMPLETED","sponsor":"D. Bradley Welling, MD, PhD","startDate":"2016-10","conditions":["Tympanic Membrane Perforation"],"enrollment":57,"completionDate":"2020-03"},{"nctId":"NCT05708274","phase":"PHASE1","title":"Pharmacological Agents for Chronic Spinal Cord Injury (SCI)","status":"COMPLETED","sponsor":"Bronx VA Medical Center","startDate":"2023-01-20","conditions":["Spinal Cord Injuries"],"enrollment":25,"completionDate":"2025-10-30"},{"nctId":"NCT06448039","phase":"PHASE1,PHASE2","title":"In-office Repair of Chronic Tympanic Membrane Perforations","status":"SUSPENDED","sponsor":"D. Bradley Welling, MD, PhD","startDate":"2024-06-15","conditions":["Chronic Tympanic Membrane Perforation"],"enrollment":20,"completionDate":"2026-12-30"},{"nctId":"NCT04960384","phase":"PHASE2","title":"Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2022-05-27","conditions":["Tympanic Membrane Perforation"],"enrollment":52,"completionDate":"2025-10-27"},{"nctId":"NCT06626516","phase":"PHASE1,PHASE2","title":"Tebentafusp-tebn With LDT in Metastatic UM","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2025-10-15","conditions":["Metastatic Uveal Melanoma"],"enrollment":109,"completionDate":"2032-08"},{"nctId":"NCT06968299","phase":"NA","title":"Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological","status":"RECRUITING","sponsor":"SunWay Biotech Co., LTD.","startDate":"2025-05-20","conditions":["Cognitive Functions Perceptual Disturbances","Cognitive Function Abnormal","Sleep","Psychological"],"enrollment":50,"completionDate":"2025-12-30"},{"nctId":"NCT04701034","phase":"PHASE2","title":"Intravenous Immunoglobulin and Prednisolone for RPL After ART.","status":"COMPLETED","sponsor":"Aalborg University Hospital","startDate":"2021-01-28","conditions":["Habitual Abortion","Recurrent Pregnancy Loss","Fertility Disorders","Miscarriage"],"enrollment":80,"completionDate":"2024-04-18"},{"nctId":"NCT06126731","phase":"PHASE1,PHASE2","title":"Combination Study of Antibiotics With Enzalutamide (PROMIZE)","status":"RECRUITING","sponsor":"Institute of Cancer Research, United Kingdom","startDate":"2023-11-02","conditions":["Metastatic Castration-Resistant Prostate Cancer (mCRPC)"],"enrollment":39,"completionDate":"2027-06-30"},{"nctId":"NCT03944733","phase":"NA","title":"Iron Status, Maternal Depressive Symptoms, and Mother-child Interactions","status":"WITHDRAWN","sponsor":"Penn State University","startDate":"2019-12-01","conditions":["Iron Deficiency Anemia"],"enrollment":0,"completionDate":"2020-12-30"},{"nctId":"NCT07237113","phase":"NA","title":"Muscle Recovery After Omega-3 Supplementation","status":"COMPLETED","sponsor":"Instituto de Ciencias de la Salud, Universidad de O'Higgins","startDate":"2021-09-01","conditions":["Damage Muscle"],"enrollment":30,"completionDate":"2024-09-01"},{"nctId":"NCT06806228","phase":"PHASE1","title":"Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)","status":"SUSPENDED","sponsor":"Petrov, Andrey","startDate":"2026-03-20","conditions":["Glioblastoma Multiforme","Diffuse Midline Glioma, H3 K27M-Mutant","Gliosarcoma","Giant Cell Glioblastoma","GBM"],"enrollment":10,"completionDate":"2027-12-10"},{"nctId":"NCT05424276","phase":"PHASE2","title":"A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease","status":"COMPLETED","sponsor":"ABLi Therapeutics, Inc.","startDate":"2023-05-15","conditions":["Parkinson Disease"],"enrollment":137,"completionDate":"2025-09-13"},{"nctId":"NCT07232927","phase":"NA","title":"Evaluation of Hemostatic Agents in Partial Nephrectomy","status":"COMPLETED","sponsor":"Ankara University","startDate":"2023-01-02","conditions":["Partial Nephrectomy","Hemostatic Agents","Localized Renal Cell Carcinoma"],"enrollment":150,"completionDate":"2024-12-27"},{"nctId":"NCT06599918","phase":"PHASE2","title":"Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)","status":"RECRUITING","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2024-04-23","conditions":["Fatty Liver","Obesity","Hepatic Fibrosis","NAFLD","Nicotinamide","Overweight and Obese Adults"],"enrollment":30,"completionDate":"2028-12"},{"nctId":"NCT05185583","phase":"PHASE2","title":"Methylphenidate in Childhood Apraxia of Speech","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-03-14","conditions":["Childhood Apraxia of Speech"],"enrollment":18,"completionDate":"2025-10-27"},{"nctId":"NCT05112926","phase":"NA","title":"Effectiveness and Safety of Embosphere Microspheres for Embolization of the Geniculate Artery for the Treatment of Pain With Known Moderate to Severe Knee Osteoarthritis","status":"COMPLETED","sponsor":"University of Miami","startDate":"2022-12-08","conditions":["Knee Osteoarthritis"],"enrollment":9,"completionDate":"2025-10-21"},{"nctId":"NCT06351644","phase":"PHASE1,PHASE2","title":"ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma","status":"TERMINATED","sponsor":"Adriana Rossi","startDate":"2024-10-02","conditions":["Relapsed and/or Refractory Multiple Myeloma"],"enrollment":2,"completionDate":"2025-04-28"},{"nctId":"NCT06928272","phase":"PHASE3","title":"Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study","status":"RECRUITING","sponsor":"Douglas D. Fraser","startDate":"2025-09-10","conditions":["Long COVID"],"enrollment":348,"completionDate":"2027-12"},{"nctId":"NCT07222878","phase":"PHASE1","title":"Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042","status":"RECRUITING","sponsor":"NeuroPro Therapeutics, Inc.","startDate":"2025-09-29","conditions":["Epilepsy","Alzheimer Disease","Epilepsy Intractable"],"enrollment":8,"completionDate":"2025-11-15"},{"nctId":"NCT04266275","phase":"PHASE2","title":"Topical Curcumin for HPV Related Cervical Disease","status":"NOT_YET_RECRUITING","sponsor":"Lisa Flowers","startDate":"2026-03","conditions":["Neoplasm Cervix"],"enrollment":200,"completionDate":"2027-10"},{"nctId":"NCT06528457","phase":"PHASE2","title":"Study to Examine the Effects of Oral Fenretinide","status":"COMPLETED","sponsor":"Island Pharmaceuticals","startDate":"2024-09-05","conditions":["Dengue"],"enrollment":15,"completionDate":"2025-07-21"},{"nctId":"NCT03737214","phase":"PHASE3","title":"A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-12-18","conditions":["Fabry Disease"],"enrollment":107,"completionDate":"2029-11"},{"nctId":"NCT07217951","phase":"","title":"Assessing the Feasibility of Multi-modal Biosensing for Monitoring Mobility and Cognition in Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Tufts University","startDate":"2025-12","conditions":["Chronic Stress","Systemic Inflammation","Mobility and Independence"],"enrollment":20,"completionDate":"2028-09"},{"nctId":"NCT06620523","phase":"PHASE2","title":"Prevent Cardiac Surgery Associated AKI Trial","status":"RECRUITING","sponsor":"George Washington University","startDate":"2024-07-18","conditions":["Renal Failure","Coronary Artery Disease","Surgery","Surgery-Complications"],"enrollment":242,"completionDate":"2028-06-17"},{"nctId":"NCT07206342","phase":"NA","title":"Evaluation of the Non-inferiority of Resorbable Gelatin Embolization Compared to Embolization Combined With Endometrial Aspiration for the Management of Hemorrhagic Uterine Vascular Abnormalities Following Premature Termination of Pregnancy","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Grenoble","startDate":"2026-01-01","conditions":["Hemorrhage, Obstetric","Uterine Abnormality","Uterine Artery Embolization","Vaginal Bleeding During Pregnancy","Vaginal Bleeding"],"enrollment":110,"completionDate":"2028-12-31"},{"nctId":"NCT07179523","phase":"EARLY_PHASE1","title":"Clinical Evaluation of the Effectiveness of Biomimetic Hemostatic Sponges ColiSorB Following Dental Extraction","status":"COMPLETED","sponsor":"Sara Omar","startDate":"2023-09-01","conditions":["Molar Extraction Socket"],"enrollment":30,"completionDate":"2023-10-01"},{"nctId":"NCT04925960","phase":"PHASE3","title":"Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG","status":"TERMINATED","sponsor":"Maggie's Pearl, LLC","startDate":"2022-11-10","conditions":["Pmm2-CDG","Phosphomannomutase 2 Deficiency","Phosphomannomutase 2 Congenital Disorder of Glycosylation","Phosphomannomutase II Congenital Disorder of Glycosylation","Phosphomannomutase II Deficiency"],"enrollment":42,"completionDate":"2025-02-28"},{"nctId":"NCT03512418","phase":"PHASE3","title":"Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps)","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2019-06-20","conditions":["HIV Infections","Substance Use Disorders"],"enrollment":30,"completionDate":"2024-04-10"},{"nctId":"NCT06085963","phase":"NA","title":"Nasal Allergen Challenge Test as a Method to Detect Clinical Reactivity Against Birch Pollen","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2023-02-01","conditions":["Allergic Rhinitis Due to Pollen"],"enrollment":89,"completionDate":"2024-12-31"},{"nctId":"NCT02295059","phase":"NA","title":"Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2017-08-09","conditions":["Breast Cancer"],"enrollment":80,"completionDate":"2026-06-22"},{"nctId":"NCT04977388","phase":"PHASE1,PHASE2","title":"NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome","status":"COMPLETED","sponsor":"Stephen G. Kaler, MD","startDate":"2021-07-12","conditions":["Menkes Disease","Occipital Horn Syndrome"],"enrollment":3,"completionDate":"2024-06-29"},{"nctId":"NCT05088408","phase":"NA","title":"Comparative Study Between Colonoscopy Bowel Preparation With Clear Liquids, With and Without Two Servings of High Energy Nutritional Supplement","status":"COMPLETED","sponsor":"Clínica de Gastroenterologia","startDate":"2020-10-30","conditions":["Colonoscopy","Bowel Preparation"],"enrollment":299,"completionDate":"2022-05-28"},{"nctId":"NCT06681857","phase":"NA","title":"Maxillary Sinus Floor Elevation With Gelatin Sponge Versus Allogenic Demineralized Bone Matrix","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2024-12-01","conditions":["Maxillary Sinus Disease"],"enrollment":14,"completionDate":"2025-09-09"},{"nctId":"NCT07154121","phase":"NA","title":"Efficacy Evaluation of 5-Fluorouracil as an Adjuvant to Endoscopic Dacryocystorhinostomy in Managing Primary Acquired Nasolacrimal Duct Obstruction With Small Lacrimal Sac: A Randomized Controlled Study","status":"RECRUITING","sponsor":"Zhongshan Ophthalmic Center, Sun Yat-sen University","startDate":"2025-09-08","conditions":["Primary Acquired Nasolacrimal Duct Obstruction"],"enrollment":100,"completionDate":"2026-07-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral"},"crossReferences":{"MMSL":"NOCODE","NDDF":"002549","VANDF":"4019160","RXNORM":"4716","UMLSCUI":"C0017237","chemblId":"CHEMBL2108518","ChEMBL_ID":"CHEMBL2108518","KEGG_DRUG":"D00115","DRUGBANK_ID":"DB11242","SNOMEDCT_US":"373531009","MESH_DESCRIPTOR_UI":"D005780"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":38553,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 29","pmid":"41906015","title":"Development and Pre-clinical Feasibility of a Catheter-Based Platform for Interventional Phase-0 Drug Response Measurements.","journal":"Annals of biomedical engineering"},{"date":"2026 Mar 29","pmid":"41904264","title":"Multimodal intra-subject characterization of abdominal aortic aneurysm pathophysiology: a case study.","journal":"Biomechanics and modeling in mechanobiology"},{"date":"2026 Jun 1","pmid":"41903972","title":"Novel microfluidic gelatin-paper-based chip for sensitive colorimetric detection of urine albumin.","journal":"Analytica chimica acta"},{"date":"2026 Mar 26","pmid":"41903697","title":"Valorization of dragon fruit peel into advanced functional carbon quantum dot/betalain composite films for smart and active beef packaging.","journal":"Bioresource technology"},{"date":"2026 Mar 28","pmid":"41903101","title":"Treatment of myocardial infarction via implantation of electroactive alginate/gelatin cardiac patch seeded with mesenchymal stem cells in a rat model.","journal":"Drug delivery and translational research"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"GELATIN","companyName":"","companyId":"","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":3,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:22:30.697651+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}